Opioid Consumption clinical trials

Explore recruiting opioid consumption clinical trials.

Recruiting opioid consumption studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Opioid Consumption trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intravenous lidocaine and post operative recovery after liver surgery – a randomized double blinded study

Sweden

Phase II and Phase III (Integrated) EU CTIS Study details

Evaluation of the efficacy of iloprost in the management of vaso-occlusive crises in adult patients with sickle cell: a multicentre, randomised, double-blind, placebo-controlled study _ PROSTASICKLE

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Analgesic efficacy of wound infiltration vs ultrasound-guided transversus abdominis plane block in laparoscopic colorectal surgery

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Perioperative methadone compared to placebo in elderly hip fracture patients – a randomized controlled trial. Phase two of the MetaHip trial

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section - a randomised, blinded, clinical, controlled, multicentre trial.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

PARASTOP – Paracetamol with Strong Opioids. A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Opioid Consumption trials by city

Opioid Consumption in Toronto Opioid Consumption in Vancouver Opioid Consumption in Montreal Opioid Consumption in Calgary Opioid Consumption in Edmonton Opioid Consumption in Ottawa Opioid Consumption in Winnipeg Opioid Consumption in Quebec City Opioid Consumption in Hamilton Opioid Consumption in Kitchener Opioid Consumption in London Opioid Consumption in Halifax Opioid Consumption in New York Opioid Consumption in Los Angeles Opioid Consumption in Chicago Opioid Consumption in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease